guillain-barré syndrome in a patient with … · guillain-barré syndrome in a patient with...

13
Guillain - Barré Syndrome in a Patient with Pneumococcal Meningitis An Uncommon Complication of a Common Infection ACP Wisconsin, September 2017 Jesse Maupin, MD (PGY-2) University of Wisconsin Hospital and Clinics Internal Medicine

Upload: phamcong

Post on 05-Oct-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

Guillain-Barré Syndrome in a Patient with

Pneumococcal MeningitisAn Uncommon Complication of a Common InfectionACP Wisconsin, September 2017

Jesse Maupin, MD (PGY-2)University of Wisconsin Hospital and ClinicsInternal Medicine

Patient PresentationHPI: Unvaccinated 23 M with no significant PMH

presents with headache, nausea, and vomiting.HPI:7 days of progressive headache, confusion, neck pain, fever, nausea, and vomiting.

PMH, PSH, FH, MedicationsNone reported

Social HistoryPatient lives in rural WI in Amish communityNo previously documented healthcare encountersWorks as a carpenterNo smoking, alcohol, IVDU, sexual activity, or sick contactsDrinks well water

Review of Systems(+) Fever, Headache, Neck Stiffness, Confusion, Vomiting

(-) Trauma, Diarrhea, Cough, Dyspnea

EXAM� T 37.8C, HR 76, RR 16, BP 135/58 mmHg, SpO2 95% RA� GEN: Somnolent, arousable to noxious stimuli, moves

all 4 extremities spontaneously� Neck: Nuchal rigidity is present, with positive

Brudzinski’s sign� Neuro: Normal tone, reflexes 1+ throughout, bilateral

leg strength diminished at 3/5� Skin: No rash

Physical Exam

Labs & ImagingChemistriesAST 22ALT 22Alk Phos 74Total Bilirubin1.0Total Protein 7.8Albumin 4.0Calcium 9.5

CBC Differential• 87% Neutrophils • 5% Lymphocytes• 3% Monocytes

CSF Gram Stain: Gram +ve cocci CSF and Blood Cultures: Positive for Streptococcus pneumoniae

CSFProtein 275.9Glucose <50 Lactate 10.4 Nuc. Cells 9,644PMNs 98%

Non-Contrast Head CTNo evidence of infarct, abscess, or ventricular enlargement.

Patient:� Bacteremic pneumococcal meningitis in an unvaccinated

individual within a community with impaired herd immunity� Unclear if bacteremia preceded CNS invasion� No foci of infection identified� Penicillin-sensitive pathogen

More Broadly:� CNS invasion theorized via cribriform plate transit� No correlation between non-immunized status and pneumococcaldisease.

Assessment

� Hospital Course:◦ Ceftriaxone, Vancomycin, Dexamethasone ◦ Febrile, but rapid recovery of mental status◦ Developed weakness and numbness of legs à

areflexia and flaccid paralysis◦ Neurogenic bladder and bradycardia◦ EMG findings consistent with a demyelinating

polyneuropathy◦ Cessation of ascending paralysis after IVIG◦ Gradual improvement in leg strength

Management

Guillain-Barré Treatment

Prevention

Antecedent Infection

Supportive Care

Respiratory Support

Dysautonomia

Disease Modifying

Plasma Exchange

IVIG

Campylobacter jejuni

� Streptococcal meningitis is very common� Guillain-Barre is a rare complication� GBS is typically seen after other infections� Combined myelin-axonal degradation � IVIG has a level 1 evidence rating

Take-Home Points

Dr. Jeremy Smith, MDDr. Sean O’Neill, MD

Internal Medicine

Dr. Bennett Vogelman, MDUWHC IM Program Director

Dr. Nicholas Stanek, MDNeurology

Dr. Rachna Unnithan, MDDr. Justin Bucci, MD

Dr. Benjamin Ciske, MDDr. Saad Arain, MD

Siddique Akram, MS4

Acknowledgements

1. Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366(24):2294–304.

2. Williamson G, Ahmed B, Kumar P, Ostrov B. Vaccine-Preventable Diseases Requiring Hospitalization. Pediatrics Aug 2017, c20170298; DOI: 10.1524/peds.2017-0278

3. Imohl M, Moller J, Perniciaro S, van der Linden M, Aktas O. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: Results of 20 years of nationwide surveillance in Germany. BMC Infectious Diseases. 2015;15(1)

4. Bianchi, G. & Domenighetti, G. Intensive Care Med (2006) 32: 338. doi:10.1007/s00134-005-0028-y

5. White B, Diggle M, Todd A, et al. A novel pneumococcus with a new association. Travel Med Infect Dis. 2011;9:84–87.

6. Nachamkin I, Allos BM, Ho T. Campylobacter Species and Guillain-Barré Syndrome. Clinical Microbiology Reviews. 1998;11(3):555-567.

References

Questions?Thank You

� 7 days post-discharge: Persistent bilateral lower extremity paralysis, full neurogenic bladder

� 47 days post-discharge: Residual weakness and fatigue, only nocturnal straight caths

� Did not return for neurology follow-up

Follow-up

Re-AssessmentUnilateral facial nerve palsy

Areflexia in affected limbs

Progressive, symmetric leg weakness with mild sensory loss

Autonomic dysfunction

Electrodiagnostic abnormalities consistent with GBS

Inflamed peripheral nerve